[Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations manually curated.
DisGeNET evidence - CURATED